- Supported exchanges /
- ST /
- LPGO.ST
Lipigon Pharmaceuticals AB (LPGO ST) stock market data APIs
Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company's product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease; a gene therapy project for the treatment of the rare disease lipodystrophy; and RNA drug project for acute respiratory distress syndrome. Lipigon Pharmaceuticals AB (publ) has a collaboration agreement with HitGen Inc. for the development of small molecules for the treatment of dyslipidemia. The company was incorporated in 2010 and is based in Umeå, Sweden.
Lipigon Pharmaceuticals AB Financial Data Overview
| 0.3646 | |
| 0.002 | |
| - | |
| 0.232 | |
| 0.2452 | |
| 0.112-0.598 | |
| 25 127 K | |
| 148 M | |
| 9 326 K | |
| -0.0032 | |
| 0.578 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Lipigon Pharmaceuticals AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 9 326 K
- EBITDA -21 853 800
- Earnings Per Share -0.26
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Lipigon Pharmaceuticals AB Earnings via APIs
- Latest Release 2024-06-30
- EPS/Forecast NaN
Get Lipigon Pharmaceuticals AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
